
San Francisco beats Los Angeles in international City Nature Challenge
But what lies hidden beneath these cold waters, where the land meets the Pacific Ocean, is equally jaw-dropping. Seen only at low tide, it's a whole different kind of world teeming with treasure and life.
"This place is one of the places that you can come at low tide, and you can see the greatest diversity of life," said Professor Rebecca Johnson.
Dr. Johnson is the director of biodiversity and community science at the California Academy of Sciences. Jessica Carver is the associate manager of community service and works with Dr. Johnson at the academy.
"Every time is so amazing. It's always so different," Carver remarked as she surveyed the massive reef, with multiple tide pools.
Recently, at the crack of dawn, a group including Johnson, Carver, and volunteer community scientist Kristi Brakken gathered in the parking lot at Mavericks Beach to document wildlife and participate in the City Nature Challenge. Joining Brakken was her daughter, Kelly.
The City Nature Challenge began 10 years ago as a friendly competition between two cities: San Francisco and Los Angeles. Today, it's an international event that involves almost 670 cities and metro areas across six continents. Johnson is a co-founder.
The idea is that volunteers around the world photograph as many wild plants and animals as possible in their own communities, on four designated days.
"People have made over seven million observations of nature. This gives us an ongoing annual census of where species are across the globe," Johnson explained.
She called the location at Mavericks "magical."
"You can see this huge diversity of things: you can see seaweeds, crabs, shrimps, sponges, anemones," she said.
There's a lot to look at: 650 different species live in the tide pools alone, including ochre sea stars, crabs, California mussels, and all kinds of barnacles and seaweed. But perhaps the most mesmerizing find is the vibrantly colored creatures known as nudibranchs.
"This place is an amazing hot spot for diversity," noted Olivia VanDamme, a community science coordinator with the academy.
Kelly came to catch and glimpse and was not disappointed.
"This officially has made the trip worthwhile," she said as she pointed at one tiny nudibranch and laughed.
Kelly Brakken
Armed with smartphones, the team snapped pictures of all the wildlife they saw. On their phones, they downloaded a free special app known as iNaturalist. The app allows all the participants to record their observations. The program identified the species and then tallied and shared their findings with all involved in the challenge.
The data is important for scientists who study long-term trends.
"It's like an early warning system, often in what is going on in these very delicate ecosystems," Lizzy Edson explained.
Edson is the biodiversity data manager for the Center of Biodiversity Sciences at the academy and also works with Johnson. After a few hours, the team noticed the rising tides and realized it was time to wrap up their observations and leave.
The Brakkens left with a new appreciation.
"With the current changing climate, we don't know how long we'll have the ability to see these creatures and see them prospering unless we can make really rapid changes," Kelly said.
"So that we can be more aware and take better care of our earth," added her mom, Kristi.
The competition ended on April 28. The winners included La Paz, Bolivia, for the most observations and the most participants; Cochabamba in Central Bolivia recorded the highest number of species; and San Francisco beat L.A. in all three categories: observations, participants, and recorded species.
But the biggest winner, according to Johnson, is our understanding of nature where or near people live, which is really important for protecting, understanding, and conserving the world's biodiversity.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Snail's regenerating eye may unlock cure for human blindness
On August 6, 2025, researchers in California revealed how freshwater apple snails can regrow lost eyes. The study, published in Nature Communications, shows the process mirrors human eye anatomy and genetics. Scientists hope isolating the key genes could one day enable humans to regenerate damaged eyes.


Geek Tyrant
10 hours ago
- Geek Tyrant
Two New STAR TREK Movies in the Works and The Franchise is a High Priority For Paramount Pictures — GeekTyrant
Paramount and Skydance Media are making Star Trek a major part of their post-merger film strategy. According to a new report from Deadline, the studio has two Star Trek movies currently in development, each taking the franchise in a different direction. One project is being directed by Toby Haynes ( Star Wars: Andor ) with a script from Seth Grahame-Smith. This film will introduce 'brand new characters,' offering a completely fresh crew and story. The other project is written by The Flight Attendant creator Steve Yockey and will center on the iconic team of Kirk, Spock, and the Enterprise. There are no release dates yet, and it's unclear which film will go into production first. The only certainty from the report is that Star Trek is now a 'high priority' for Paramount moving forward. The last Star Trek film to hit theaters was 2016's Star Trek Beyond , which was well-reviewed but underperformed financially, earning $343.3 million worldwide on a $185 million budget. Since then, multiple Star Trek movie concepts have been announced and scrapped, including Quentin Tarantino's standalone idea and Noah Hawley's version, which was abandoned partly because its plot involved a pandemic. Interestingly, Hawley's canceled film also planned to feature an all-new crew, which is an approach Haynes' project is now picking up. While nostalgia-driven sequels remain the industry's comfort zone, Star Trek has always thrived by creating new ensembles, from The Next Generation to Deep Space Nine . If the franchise wants to stay relevant for decades to come, introducing new characters is essential. That said, the appeal of another Kelvin Timeline film with Chris Pine, Zachary Quinto, and the rest of the cast is undeniable. Yockey's project could serve as a fitting send-off for this version of the Enterprise crew while Haynes' film sets the stage for a new era. If Paramount plays it right, fans might get both, a celebration of the past and a bold step into the future.
Yahoo
11 hours ago
- Yahoo
Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 13, 2025
SAN DIEGO, Aug. 5, 2025 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that it will issue financial results for its fiscal first quarter ended June 30, 2025, at 4:15 p.m. ET on Wednesday, August 13, 2025. Management will host a conference call on Wednesday, August 13, 2025, at 4:30 p.m. ET to review financial results and recent corporate developments. Following management's formal remarks, there will be a question and answer session. Interested parties can register for the conference call by navigating to Please note that registered participants will receive their dial-in number upon registration. Interested parties without internet access or unable to pre-register may dial in by calling: PARTICIPANT DIAL IN (TOLL FREE): 1-844-836-8741PARTICIPANT INTERNATIONAL DIAL IN: 1-412-317-5442 All callers should ask for the Aethlon Medical, Inc. conference call. A replay of the call will be available approximately one hour after the end of the call through September 13, 2025. The replay can be accessed via Aethlon Medical's website or by dialing 1-877-344-7529 (domestic) or 1-412-317-0088 (international) or Canada toll free at 1-855-669-9658. The replay conference ID number is 1454680. About the Hemopurifier® The Aethlon Hemopurifier is an investigational medical device designed to remove enveloped viruses and tumor-derived extracellular vesicles (EVs) from circulation. It is used extracorporeally with a blood pump and combines plasma separation, size exclusion, and affinity binding using a plant lectin resin that targets mannose-rich surfaces found on EVs and viruses. EVs released by solid tumors are believed to play a role in metastasis and the resistance to immunotherapies and chemotherapy. Removal of enveloped viruses and extracellular vesicles has been demonstrated in both vitro studies and human subjects. The Hemopurifier holds a U.S. Food and Drug Breakthrough Device Designation for: The treatment of individuals with advanced or metastatic cancer unresponsive to or intolerant of standard-of-care therapy; and the treatment of life-threatening viruses not addressed with approved therapies. About Aethlon Medical, Inc. Aethlon Medical, Inc. (Nasdaq: AEMD) is a clinical-stage medical device company headquartered in San Diego, California. Aethlon is advancing the Hemopurifier, to address unmet needs in oncology and infectious disease, using a novel platform designed to selectively remove circulation pathogenic targets from biologic fluids. For more information, visit and follow the company on LinkedIn. Forward Looking StatementsThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that involve risks and uncertainties. Statements containing words such as "may," "believe," "anticipate," "expect," "intend," "plan," "project," "will," "projections," "estimate," "potentially" or similar expressions constitute forward-looking statements. Such forward-looking statements are subject to significant risks and uncertainties and actual results may differ materially from the results anticipated in the forward-looking statements. These forward-looking statements are based upon Aethlon's current expectations and involve assumptions that may never materialize or may prove to be incorrect. All forward-looking statements contained in this press release speak only as of the date on which they were made. Except as may be required by law, the Company does not intend, nor does it undertake any duty, to update this information to reflect future events or circumstances. Company Contact:Jim FrakesChief Executive Officer and Chief Financial OfficerAethlon Medical, Inc. Jfrakes@ Investor Contact:Susan NoonanS.A. Noonan Communications, LLCsusan@ View original content: SOURCE Aethlon Medical, Inc.